These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 2816898)

  • 21. Family history and risk of ovarian cancer.
    La Vecchia C; Parazzini F; Negri E; Del Pino D; Franceschi S
    Int J Cancer; 1996 Sep; 67(6):903-4. PubMed ID: 8824566
    [No Abstract]   [Full Text] [Related]  

  • 22. Reply to: Alcohol consumption and ovarian cancer risk in a population-based case-control study by Peterson et al.
    Gallus S; Scotti L; Talamini R; Franceschi S; Dal Maso L; Negri E; La Vecchia C
    Int J Cancer; 2007 Dec; 121(11):2578-9. PubMed ID: 17680558
    [No Abstract]   [Full Text] [Related]  

  • 23. Risk factors for epithelial ovarian cancer in Beijing, China.
    Chen Y; Wu PC; Lang JH; Ge WJ; Hartge P; Brinton LA
    Int J Epidemiol; 1992 Feb; 21(1):23-9. PubMed ID: 1544753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Risk of ovarian cancer in women treated for infertility].
    Daya S
    Contracept Fertil Sex; 1994 Oct; 22(10):593-6. PubMed ID: 7804376
    [No Abstract]   [Full Text] [Related]  

  • 25. [Risk of ovarian cancer in women treated for infertility].
    Daya S
    Contracept Fertil Sex; 1995 Jan; 23(1):7-11. PubMed ID: 7881493
    [No Abstract]   [Full Text] [Related]  

  • 26. Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer.
    Wenham RM; Schildkraut JM; McLean K; Calingaert B; Bentley RC; Marks J; Berchuck A
    Clin Cancer Res; 2003 Oct; 9(12):4396-403. PubMed ID: 14555511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ovarian cancer and selected life style habits].
    Pawlega J; Rachtan J; Dyba T
    Ginekol Pol; 1995 Jan; 66(1):41-5. PubMed ID: 8522213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ovarian cancer risk and common variation in the sex hormone-binding globulin gene: a population-based case-control study.
    Garcia-Closas M; Brinton LA; Lissowska J; Richesson D; Sherman ME; Szeszenia-Dabrowska N; Peplonska B; Welch R; Yeager M; Zatonski W; Chanock SJ
    BMC Cancer; 2007 Apr; 7():60. PubMed ID: 17411440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physical activity and epithelial ovarian cancer risk: a case-control study in China.
    Zhang M; Lee AH; Binns CW
    Int J Cancer; 2003 Jul; 105(6):838-43. PubMed ID: 12767071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetics of uro-genital cancer: prostate and ovary.
    Lamia BJ
    Tunis Med; 2005 Dec; 83 Suppl 12():20-2. PubMed ID: 16430060
    [No Abstract]   [Full Text] [Related]  

  • 31. Case study: Mary is a healthy 33-year-old woman concerned about her risk of breast cancer.
    Weber BL; Watson P; Stefanek ME; Wells NL; Helzlsouer KJ
    Cancer Pract; 1994; 2(4):252-5. PubMed ID: 7858651
    [No Abstract]   [Full Text] [Related]  

  • 32. Missense polymorphisms in BRCA1 and BRCA2 and risk of breast and ovarian cancer.
    Dombernowsky SL; Weischer M; Freiberg JJ; Bojesen SE; Tybjaerg-Hansen A; Nordestgaard BG
    Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2339-42. PubMed ID: 19661094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Familial invasive and borderline ovarian tumors by proband status, age and histology.
    Hemminki K; Granström C
    Int J Cancer; 2003 Jul; 105(5):701-5. PubMed ID: 12740921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BRCA1 and BRCA2 mutations in Turkish familial and non-familial ovarian cancer patients: a high incidence of mutations in non-familial cases.
    Yazici H; Glendon G; Yazici H; Burnie SJ; Saip P; Buyru F; Bengisu E; Andrulis IL; Dalay N; Ozcelik H
    Hum Mutat; 2002 Jul; 20(1):28-34. PubMed ID: 12112655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Family history of reproductive cancers and ovarian cancer risk: an Italian case-control study.
    Parazzini F; Negri E; La Vecchia C; Restelli C; Franceschi S
    Am J Epidemiol; 1992 Jan; 135(1):35-40. PubMed ID: 1736658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial ovarian cancer: a population-based case-control study.
    Schildkraut JM; Thompson WD
    Am J Epidemiol; 1988 Sep; 128(3):456-66. PubMed ID: 3414654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case-control study.
    Bjørge T; Lie AK; Hovig E; Gislefoss RE; Hansen S; Jellum E; Langseth H; Nustad K; Tropé CG; Dørum A
    Br J Cancer; 2004 Nov; 91(10):1829-34. PubMed ID: 15477862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The evaluation of the data collection process for a multicenter, population-based, case-control design.
    Wingo PA; Ory HW; Layde PM; Lee NC
    Am J Epidemiol; 1988 Jul; 128(1):206-17. PubMed ID: 3381827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ovarian cancer risk and family history.
    Foulkes WD; Narod SA
    Lancet; 1997 Mar; 349(9055):878. PubMed ID: 9121280
    [No Abstract]   [Full Text] [Related]  

  • 40. Coffee intake, variants in genes involved in caffeine metabolism, and the risk of epithelial ovarian cancer.
    Kotsopoulos J; Vitonis AF; Terry KL; De Vivo I; Cramer DW; Hankinson SE; Tworoger SS
    Cancer Causes Control; 2009 Apr; 20(3):335-44. PubMed ID: 18941913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.